Tudor Investment Corp
EVFM

Tudor Investment Corp’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Tudor Investment Corp’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,239
Closed -$45K – 1947
2020
Q4 		$45K Buy
+1,239
New +$44.8K ﹤0.01% 1289
2020
Q3 		– Sell
-17,184
Closed -$729K – 1621
2020
Q2 		$729K Buy
+17,184
New +$1.16M 0.04% 591

Other funds holding EVFM

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $12.1B AUM 29.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tudor Investment Corp's EVFM Position: Q1 2021 in Review

Tudor Investment Corp sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q1 2021, closing a stake of 1,239 shares — an estimated $45K sold.

Tudor Investment Corp first reported a position in EVFM in Q2 2020 and held it in 2 quarters. The position peaked at $729K in Q2 2020. 103 funds tracked by Wall St. Rank hold EVFM as of Q1 2021.

  • Tudor Investment Corp reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Tudor Investment Corp sold 1,239 Evofem Biosciences, Inc. Common Stock shares in Q1 2021, an estimated $45K.
  • Tudor Investment Corp first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Tudor Investment Corp's Evofem Biosciences, Inc. Common Stock position peaked at $729K in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q1 2021.

Based on Tudor Investment Corp's 13F filing for Q1 2021, filed 17 May 2021.